what to know about glp 1 for weight loss GLP-1 Loss: Everything You Need in 2026 GLP-1 and health: Beyond weight

Effect of glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors among obese/overweight individuals treated with antipsychotic drug classes: an updated systematic review and meta-analysis of randomized controlled trials

The New England Journal of Medicine, 393 (11), 10771087

Patients enquiring about GLP-1 agonists for alcohol problems should be directed to evidence-based treatments currently available through NHS addiction services, including community alcohol teams, specialist clinics, and psychological interventions such as cognitive behavioural therapy and motivational enhancement therapy

it depends on baseline health status, the reason for seeking therapy, and how the body responds to initial sessions

Those who took tirzepatide lost an average of 5.9% of their body weight after three months

Peptides are not surgical replacements, but they may complement non-invasive aesthetic and wellness programs